Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Riken Vitamin Co., Ltd. ( (JP:4526) ) is now available.
Riken Vitamin Co., Ltd. has completed an additional repurchase of 53,300 shares of its common stock on the Tokyo Stock Exchange between March 1 and March 23, 2026, at a total cost of ¥156,067,693. This latest transaction forms part of a broader share buyback program authorized by the board in April 2025, aimed at enhancing capital efficiency and shareholder value.
Under the board-approved program, the company had set an upper limit of 1,000,000 shares and ¥2 billion for repurchases through March 24, 2026. As of March 23, 2026, Riken Vitamin has acquired a cumulative 696,500 shares for approximately ¥1.9999 billion, effectively utilizing nearly the entire authorized budget and signaling a strong commitment to capital returns, which may support its share price and appeal to investors.
The most recent analyst rating on (JP:4526) stock is a Buy with a Yen3371.00 price target. To see the full list of analyst forecasts on Riken Vitamin Co., Ltd. stock, see the JP:4526 Stock Forecast page.
More about Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd. is a Japanese company listed on the Tokyo Stock Exchange Prime Market under securities code 4526. The company operates in the food and chemical sectors, focusing on vitamin-related and processed food ingredients for domestic and international markets.
Average Trading Volume: 68,605
Technical Sentiment Signal: Buy
Current Market Cap: Yen64.28B
Find detailed analytics on 4526 stock on TipRanks’ Stock Analysis page.